Search Medical Condition
Please enter condition
Please choose location

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1207) clinical trials

Not satisfied with your current antidepressant? Consider a research study of an investigational medication that is given by injection once a month in addition to your current antidepressant. Compensation up to $600.00 is available for time & travel for this 8 visit study over approximately 26 weeks. This study is ...

Phase N/A

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Phase

A randomized, double-blind, active-controlled, multicenter study in male and female adult subjects with TRD to assess the efficacy, safety, and tolerability of flexibly dosed intranasal esketamine plus a newly initiated oral antidepressant compared with a newly initiated oral antidepressant plus intranasal placebo

Phase N/A

To assess the long-term safety and tolerability of ALKS 5461 for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)

Phase

To evaluate the efficacy of ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD) in adults who have an inadequate response to antidepressant therapy (ADT). To evaluate the safety and tolerability of ALKS 5461 in adults who have MDD and an inadequate response to ADT.

Phase

This study is a randomized, double-blind, placebo-controlled study to evaluate 3 fixed doses (5, 10, and 20 mg oral tablets) of vortioxetine once daily in the prevention of relapse in adult subjects with major depressive disorder (MDD) who have responded to acute treatment with vortioxetine.

Phase

To evaluate the efficacy, safety and tolerability of Cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD

Phase

This is a study of subjects with TRD to assess the efficacy, safety, and tolerability of intranasal esketamine plus an oral antidepressant compared to an oral antidepressant (active comparator) plus intranasal placebo.

Phase N/A

To determine if SAGE-547 Injection infused intravenously for 60 hours reduces depressive symptoms in subjects with postpartum depression (PPD) compared to placebo injection

Phase N/A

Adolescent Non-Drug Depression Study designed to study the safety and effectiveness of a non-drug treatment in adolescents with Major Depressive Disorder.

Phase N/A